CA2441096A1 - Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques - Google Patents

Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques Download PDF

Info

Publication number
CA2441096A1
CA2441096A1 CA002441096A CA2441096A CA2441096A1 CA 2441096 A1 CA2441096 A1 CA 2441096A1 CA 002441096 A CA002441096 A CA 002441096A CA 2441096 A CA2441096 A CA 2441096A CA 2441096 A1 CA2441096 A1 CA 2441096A1
Authority
CA
Canada
Prior art keywords
receptor agonists
inflammatory diseases
agonists
treatment
nicotinic receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002441096A
Other languages
English (en)
Other versions
CA2441096C (fr
Inventor
Yvon Cormier
Evelyne Israel-Assayag
Marie-Renee Blanchet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Laval
Original Assignee
Universite Laval
Yvon Cormier
Evelyne Israel-Assayag
Marie-Renee Blanchet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002341952A external-priority patent/CA2341952A1/fr
Application filed by Universite Laval, Yvon Cormier, Evelyne Israel-Assayag, Marie-Renee Blanchet filed Critical Universite Laval
Priority to CA002441096A priority Critical patent/CA2441096C/fr
Publication of CA2441096A1 publication Critical patent/CA2441096A1/fr
Application granted granted Critical
Publication of CA2441096C publication Critical patent/CA2441096C/fr
Priority to US13/178,670 priority patent/US8551983B2/en
Priority to US13/190,941 priority patent/US8557804B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002441096A 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques Expired - Fee Related CA2441096C (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002441096A CA2441096C (fr) 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques
US13/178,670 US8551983B2 (en) 2002-03-25 2011-07-08 Nicotinic receptor agonists for the treatment of inflammatory diseases
US13/190,941 US8557804B2 (en) 2002-03-25 2011-07-26 Nicotinic receptor agonists for the treatment of inflammatory diseases

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA002341952A CA2341952A1 (fr) 2001-03-23 2001-03-23 Agonistes du recepteur de la nicotine pour le traitement des maladies pulmonaires inflammatoires
CA2,341,952 2001-03-23
PCT/CA2002/000412 WO2002076434A2 (fr) 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des récepteurs nicotiniques
CA002441096A CA2441096C (fr) 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques

Publications (2)

Publication Number Publication Date
CA2441096A1 true CA2441096A1 (fr) 2002-10-03
CA2441096C CA2441096C (fr) 2009-06-30

Family

ID=29585104

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002441096A Expired - Fee Related CA2441096C (fr) 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques

Country Status (1)

Country Link
CA (1) CA2441096C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006005195A1 (fr) * 2004-07-15 2006-01-19 UNIVERSITé LAVAL Agonistes du recepteur de nicotine pour le traitement de maladies inflammatoires

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006005195A1 (fr) * 2004-07-15 2006-01-19 UNIVERSITé LAVAL Agonistes du recepteur de nicotine pour le traitement de maladies inflammatoires
KR100860903B1 (ko) * 2004-07-15 2008-09-29 유니버시티 라발 염증성 질환 치료용 니코틴성 수용체 효능제
AU2005262174B2 (en) * 2004-07-15 2009-10-08 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
AU2005262174C1 (en) * 2004-07-15 2010-05-06 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
CN101001843B (zh) * 2004-07-15 2014-08-27 拉瓦尔大学 用于治疗炎性疾病的烟碱受体激动剂

Also Published As

Publication number Publication date
CA2441096C (fr) 2009-06-30

Similar Documents

Publication Publication Date Title
IL157757A0 (en) Nicotine receptor agonists for the treatment of inflammatory diseases
WO2005070006A3 (fr) Composes nitroses et/ou nitrosyles, compositions et procede pour les utiliser
WO2004020410A3 (fr) Derives de dihydropyridinone
WO2004058769A3 (fr) Compositions utiles en tant qu'inhibiteurs des proteine kinases
WO2005039485A3 (fr) Inhibiteurs de gsk-3 et utilisations
HK1060131A1 (en) N-(3,3-dimethylindolin-6-yl) (2-Ä(4-pyridylmethyl)aminoÜ (3-pyridyl))carboxamide and pharmaceutical compositions thereof
WO2007117715A3 (fr) Modulateurs des transporteurs de cassettes de liaison de l'atp
WO2006138010A3 (fr) Implant tissulaire articule et procedes et dispositifs correspondants destines a la mise en place d'un tel implant
IL219785A (en) A process for preparing a pharmaceutical preparation containing an active ingredient and a micronized carrier / solvent
WO2007002635A3 (fr) Antagonistes cycliques a liaison c du recepteur p2y1, utiles pour traiter des etats pathologiques thrombotiques
WO2007064931A3 (fr) Derives substitues de 4-amino-pyrrolotriazine utiles dans le traitement de troubles hyperproliferatifs et de maladies associees a l'angiogenese
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
WO2006011050A3 (fr) Derives de pyridine
WO2000066138A3 (fr) Intervention metabolique au moyen d'un peptide 1 du type gucagon (glp-1) permettant d'ameliorer une lesion d'un tissu provoquee par une ischemie et une reperfusion
NO20051503L (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
WO2007064968A3 (fr) Compositions pharmaceutiques stables de 5,10 methylenetetrahydrofolate
WO2006108643A3 (fr) Composes organiques
EP1251126A3 (fr) Derives de benzenesulfonyle a substitution fluor pour le traitment d'inflammation
NO20074084L (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikamenter og medikamenter inneholdende disse
MX2022002637A (es) Proteinas de fusion terapeuticas.
WO2007075572A3 (fr) Inhibiteurs a base de purine oralement actifs de la proteine de choc thermique 90
WO2002072571A3 (fr) Pyridinyl-pyrazoles utiles pour le traitement de la bronchopneumopathie chronique obstructive
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
WO2005051931A3 (fr) Inhibiteurs de la phosphodiestérase
CA2441096A1 (fr) Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160329